Phase three was a more reliable and objective open-label, clinically controlled study involving 35 men with androgenetic alopecia. In this study, researchers used TrichoScan, a sensitive software and hardware package that uses epiluminescence to measure hair loss. Hair density was found to increase in over half of the subjects. The average increase in density was 29% after three months and 41% at six months.
New hair growth was measured in 22.5% of patients. Further, the proportion of patients with moderate to severe presentation of the skin condition seborrhea dropped by over 30%.
__________________
----------------------------------------------------------------------------------------------------------------
Maatregelen:
04-2004: minoxidil
07-2004: Dustateride (dichter haar, ook frontaal)
08-2012: RU
01-2014: Spiro cream (Toekomst)
Overige: Supplementen (algemene gezondheid, conditie en aanzien van het haar)
|